Stocksigma LogoStocksigma Logo

Zydus Lifesciences JV to Invest USD 20 Million in Sri Lanka Manufacturing Facility

Zydus Sunshine Lifesciences (Pvt) Ltd, a JV between Zydus Lifesciences and Sunshine Healthcare (part of Sunshine Holdings PLC), signed an agreement on 13th

Zydus Lifesciences JV to Invest USD 20 Million in Sri Lanka Manufacturing Facility

Zydus Lifesciences Ltd 路 Press Release 路 15 Oct 2026, 5:01 pm

Zydus Lifesciences JV to Invest USD 20 Million in Sri Lanka Manufacturing Facility Zydus Sunshine Lifesciences (Pvt) Ltd, a JV between Zydus Lifesciences and Sunshine Healthcare (part of Sunshine Holdings PLC), signed an agreement on 13th Oct'26 with the Board of Investment of Sri Lanka. The JV will establish a pharmaceutical manufacturing facility across nearly four acres in Horana, Sri Lanka, with a phased investment exceeding USD 20 million. Phase one will produce oral solid dosage forms for the Sri Lankan market, with commercial operations scheduled to begin in 2028, subject to regulatory approvals.

Original exchange filing (PDF)

More announcements from Zydus Lifesciences Ltd

All Zydus Lifesciences Ltd announcements